GE HEALTHCARE TECH.INC. (L0T) - Total Liabilities
Based on the latest financial reports, GE HEALTHCARE TECH.INC. (L0T) has total liabilities worth €26.23 Billion EUR (≈ $30.66 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of GE HEALTHCARE TECH.INC. to track the company's year-over-year net asset growth rate.
GE HEALTHCARE TECH.INC. - Total Liabilities Trend (2022–2025)
This chart illustrates how GE HEALTHCARE TECH.INC.'s total liabilities have evolved over time, based on quarterly financial data. See GE HEALTHCARE TECH.INC. (L0T) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
GE HEALTHCARE TECH.INC. Competitors by Total Liabilities
The table below lists competitors of GE HEALTHCARE TECH.INC. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
POP MART INT.GRP.DL-0001
F:735
|
Germany | €6.93 Billion |
|
Semiconductor Manufacturing International Corporation
F:MKN2
|
Germany | €17.25 Billion |
|
VeriSign Inc
NASDAQ:VRSN
|
USA | $3.51 Billion |
|
Qnity Electronics, Inc
NYSE:Q
|
USA | $6.70 Billion |
|
Compagnie Generale des Etablissements Michelin SCA
PA:ML
|
France | €16.94 Billion |
|
KeyCorp
NYSE:KEY
|
USA | $168.68 Billion |
|
Shenzhen Longsys Electronics Co. Ltd. A
SHE:301308
|
China | CN¥10.87 Billion |
|
Corpay Inc
NYSE:CPAY
|
USA | $22.19 Billion |
Liability Composition Analysis (2022–2025)
This chart breaks down GE HEALTHCARE TECH.INC.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of GE HEALTHCARE TECH.INC..
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.22 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.46 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.71 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how GE HEALTHCARE TECH.INC.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for GE HEALTHCARE TECH.INC. (2022–2025)
The table below shows the annual total liabilities of GE HEALTHCARE TECH.INC. from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €26.31 Billion ≈ $30.76 Billion |
+7.65% |
| 2024-12-31 | €24.44 Billion ≈ $28.57 Billion |
-2.81% |
| 2023-12-31 | €25.14 Billion ≈ $29.40 Billion |
+40.10% |
| 2022-12-31 | €17.95 Billion ≈ $20.98 Billion |
-- |
About GE HEALTHCARE TECH.INC.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical… Read more